To conclude, the trinity strategy of combining RT, anti-PD-L1, and anlotinib not only has the best antitumor activity but also can reverse the suppressive immune microenvironment induced by radiotherapy and significantly potentiate the tumor immune microenvironment compared with all the other treatments. Here, CD274 is linked to neoplasm.